$BMRN Recent News Biotech comeback stalls as Wall

New Post Public Reply Private Reply Replies (0) Message Board

Jun 21, 2014 at 7:21 AM

$BMRN Recent News

Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - Russ Britt
Major U.S. benchmarks pull in to first support 12:27 p.m. March 10, 2014 - Michael Ashbaugh
BioMarin shares rally as FDA mutes criticism of rare disorder drug 6:25 p.m. Nov. 15, 2013 - Russ Britt
German DAX ends at record as Europe stocks rally 12:10 p.m. Sept. 19, 2013 - Sara Sjolin
BioMarin rallies 7.6% on Roche takeover report 6:30 a.m. Sept. 19, 2013 - Sara Sjolin
S&P 500 retests the 50-day moving average 11:07 a.m. Sept. 9, 2013 - Michael Ashbaugh
Biotech ETF's breakout: bullish for stocks overall? 1:11 p.m. Sept. 5, 2013 - blogs.marketwatch.com
Acura, BioMarin mount independent rallies on their own positive news 3:28 p.m. July 1, 2013 - Russ Britt
After the close: Biogen slips, Epizyme slows, BioMarin stalls 5:57 p.m. June 4, 2013 - Russ Britt
Lofty expectations hit BioMarin in development of new cancer drugs 12:56 p.m. June 3, 2013 - Russ Britt
Get out of junk stocks now 1:14 p.m. March 22, 2013 - Mark Hulbert
Charting a slow-motion test of the 2012 peak 12:39 p.m. Jan. 11, 2013 - Michael Ashbaugh
U.S. benchmarks sustain the 2013 breakout 1:00 p.m. Jan. 4, 2013 - Michael Ashbaugh
Meet the S&P 500’s new range 12:17 p.m. Dec. 13, 2012 - Michael Ashbaugh
Charting a lackluster recovery attempt 12:49 p.m. Nov. 21, 2012 - Michael Ashbaugh
‘Aggressive’ comment hits Express Scripts 7:03 p.m. Nov. 5, 2012 - Russ Britt
BioMarin's GALNS meets primary endpoint in trial 10:24 a.m. Nov. 5, 2012 - MarketWatch.com
Biomarin says trial results meet primary endpoint 8:23 a.m. Nov. 5, 2012 - Greg Morcroft
Biomarin says its GALNS Phase III trial posiitve 8:23 a.m. Nov. 5, 2012 - Greg Morcroft
Staking out major support 10:46 a.m. Oct. 3, 2012 - Michael Ashbaugh

Biomarin Pharmaceutical (BMRN) Marked As A Barbarian At The Gate 2:19 p.m. June 20, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – SHPG CBST BMRN SLXP 7:45 a.m. June 20, 2014 - InvestorPlace.com
The Trader Daily 7:30 a.m. June 19, 2014 - RealMoney.com
Amicus Therapeutics Still A "Show Me" Story 2:11 p.m. June 12, 2014 - Seeking Alpha
Top Analyst Upgrades and Downgrades: Apache, Apple, HP, Qualcomm, Sprouts and More 7:58 a.m. June 12, 2014 - 247WallSt.com
How Will BioMarin (BMRN) Stock Respond To This Analyst Upgrade Today? 7:53 a.m. June 12, 2014 - TheStreet.com
The Trader Daily 7:30 a.m. June 12, 2014 - RealMoney.com
7 Biotechnology Stocks to Buy Now 5:45 a.m. June 11, 2014 - InvestorPlace.com
UPDATE: Credit Suisse Upgrades BioMarin Pharmaceutical 8:41 a.m. June 9, 2014 - benzinga.com
How WIll This Upgrade Affect Biomarin Pharmaceutical (BMRN) Stock Today? 7:54 a.m. June 9, 2014 - TheStreet.com
Benzinga's Top Upgrades 6:52 a.m. June 9, 2014 - benzinga.com
The Trader Daily 7:30 a.m. June 5, 2014 - RealMoney.com
Insider Trading Alert - TWO, CCL And BMRN Traded By Insiders 10:30 a.m. June 4, 2014 - TheStreet.com
Drugs Stocks On The Rise With Help From 3 Stocks 1:02 p.m. June 3, 2014 - TheStreet.com
BioMarin's Pipeline Advances - Analyst Blog 11:40 a.m. May 29, 2014 - Zacks.com
The Trader Daily 7:30 a.m. May 29, 2014 - RealMoney.com
A Tale of Diversification 2:00 p.m. May 19, 2014 - RealMoney.com
Top Biotech Stocks for Cancer Cures from Cowen 8:08 a.m. May 16, 2014 - 247WallSt.com
Insider Trading Alert - WMGI, MSM And BMRN Traded By Insiders 10:30 a.m. May 14, 2014 - TheStreet.com
'Mad Money' Lightning Round: BioMarin Is for Real 6:00 a.m. May 8, 2014 - TheStreet.com

Relypsa Adds Industry Veterans Daniel K. Spiegelman and kenneth J. Hillan to Its Board of Directors 4:06 p.m. June 19, 2014 - GlobeNewswire
Pre-Market Review on Biotechnology Equities -- Research on BioMarin Pharma, Keryx Biopharma, Amgen, and Peregrine Pharma 8:30 a.m. May 30, 2014 - PR Newswire - PRF
BioMarin Doses First Patient in Phase 3 INSPIRE Trial With BMN 701 for the Treatment of Pompe Disease 8:02 a.m. May 27, 2014 - GlobeNewswire
Prestigious Recognitions, Product Enhancements, and Earnings Releases - Analyst Notes on Discover, BlackRock, Covance, BioMarin and Vertex 8:29 a.m. May 7, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF
BioMarin to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference on May 14th and the UBS Global Healthcare Conference on May 20th 8:02 a.m. May 6, 2014 - GlobeNewswire
BioMarin Announces First Quarter 2014 Financial Results and VIMIZIM(TM) Launch Progress 4:06 p.m. May 1, 2014 - GlobeNewswire
The World Market for Orphan Drugs 6:59 p.m. April 29, 2014 - PR Newswire - PRF
BioMarin Announces European Commission Approval for VIMIZIM(R) (elosulfase alfa) for the Treatment of Morquio A Syndrome in Patients of All Ages 11:08 a.m. April 28, 2014 - GlobeNewswire
Earnings Schedules, Acquisition Agreements, and Financial Results Release - Analyst Notes on Mallinckrodt, BioMarin, Salix Pharmaceuticals, St. Jude Medical and Quest Diagnostics 8:00 a.m. April 25, 2014 - PR Newswire - PRF
BioMarin to Host First Quarter 2014 Financial Results Conference Call and Webcast on Thursday, May 1 at 5:00 p.m. ET 8:02 a.m. April 16, 2014 - GlobeNewswire
Analysts View on Biotech Equities -- Research on Organovo Holdings, BioMarin Pharma, Vertex Pharma, and Spectrum Pharma 11:15 a.m. April 15, 2014 - PR Newswire - PRF
Critical Alerts For Walt Disney, Walgreen, BioMarin Pharmaceuticals, Canadian Solar, and MannKind Released By InvestorsObserver 9:31 a.m. April 14, 2014 - PR Newswire - PRF
FDA Extends Market Exclusivity Six Months for BioMarin's Rare Disease Therapy KUVAN(R) (sapropterin dihydrochloride) Powder for Oral Solution and Tablets 8:02 a.m. April 14, 2014 - GlobeNewswire
Clinical Trial Results and Initiation, Endowment, Product Launches, and Appointments - Analyst Notes on Regeneron, Questcor, Jazz, Ariad, and BioMarin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Biotech Stocks Technical Review -- Research on BioCryst Pharma, Spectrum Pharma, BioMarin Pharma, and Vertex Pharma 11:55 a.m. March 26, 2014 - PR Newswire - PRF
BioMarin Appoints Pioneer in Personalized Medicine, Dennis J. Slamon, M.D., Ph.D., to Board of Directors 8:01 a.m. March 21, 2014 - GlobeNewswire
Critical Alerts For Voxeljet, QUALCOMM, Canadian Solar, NQ Mobile, and BioMarin Pharmaceuticals Released By InvestorsObserver 9:31 a.m. March 19, 2014 - PR Newswire - PRF
Catalyst Pharmaceutical Partners Announces Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update 8:16 a.m. March 19, 2014 - GlobeNewswire
BioMarin Announces Pricing of Public Offering of Common Stock 9:00 a.m. March 5, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Soluna Schedules Q3 2026 Earnings Call: What To Expect

Soluna's Upcoming Earnings Call: A Crucial Update Here we are again, folks—floating on the edge of another one of Soluna Holdings' earnings calls. Mark November 16, 2026, on your calendar because that's when Soluna's slated to drop its third quarter financials and walk us through the numbers. At 5:00 PM Eastern Time, they're firing up the webcast and phone lines for a...

Skyways Unleashes Skyreach: A Bold Step in Autonomous Cargo

Dropping Cargo the New Way No more messing around with runways and cumbersome logistics—Skyways just took a sledgehammer to traditional cargo transport with the launch of its Skyreach platform. This bad boy is a long-range autonomous Vertical Takeoff and Landing (VTOL) aircraft that promises to shake up the defense and commercial sectors. We've got flights kicking off...

Unquiet Nights' New Tune Echoes Rome's Eternal Lingering

Irish Rockers Unquiet Nights Celebrate a Poignant Release Ever heard of a band that takes its darn sweet time? Well, Unquiet Nights just dropped a single after sitting on it for a solid 15 years. 'Last Days of Rome' isn’t just a new tune; it’s a love letter to both music and the eternal echoes of Rome’s history. These Belfast rockers have been crafting this piece...

Xinjiang Women Embrace New Horizons in Tianshan Peaks

Scaling New Heights in Xinjiang Up there on the Tianshan Mountains, looking past those towering cliffs, what catches the eye isn't just breathtaking views but rising opportunities. In the land of Xinjiang, far from the bustling metropolises, young women are finding platforms to not just exist but to thrive. City by city, the narrative is changing as these women carve...

Invitation Homes Supports Veterans in Skilled Trades Push

A New Chapter for Veterans in the Workforce Normally when a company kicks off a partnership, it’s all about fluff and show. But this thing with Invitation Homes and the Home Builders Institute (HBI) is the real deal for veterans looking to switch gears into new careers. The objective is simple—get transitioning service members, veterans, and their families rolling...

Innovative Breaker Bar Reinvents Torque Application

A Fresh Take for Do-It-Yourselfers Ever tried to budge a stubborn bolt and felt like you were arm wrestling a gorilla? This is why a Winter Garden, Florida inventor has stepped up to the plate with the "BREAK IT," an adjustable breaker bar that promises to make this grimy task much smoother. Forget the days of waving around a cumbersome cheater bar. With this gadget,...

Envision and ju:niz Boost Germany's Energy Storage

Germany Charges Ahead with Renewable Energy Storage Germany's on a mission, folks, and it's all about beefing up their renewable energy infrastructure. Out in Bavaria, Envision Energy and ju:niz Energy are prepping a significant leap forward. They're rolling out a big undertaking—a 442 MWh battery energy storage system (BESS) with their Smareg 13 project in Vöhringen....

Strathcona and Greenfire Set Sights on Major Merger

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

AI Shopping Surge: WeFetch.ai's Bold Rebrand Move

Shifting Gears: GreenCore Solutions Becomes WeFetch.ai Here's a shift you don't see every day. GreenCore Solutions has morphed into WeFetch.ai, aiming to sail the ever-growing AI shopping seas. This isn't just a new nameplate; it's a declaration of intent to dive headfirst into the market dynamics driven by artificial intelligence. It's bold and, frankly, pretty timely....

Hyperscale Data Plans Major Stock Exchange Deal

Hyperscale's Bold Move: Exchange Offer Hits the Market Man, when a company believes its market value is out of whack, you get moves like this. Hyperscale Data, strutting under ticker symbol NYSE:GPUS, is swinging for the fences with an exchange offer, aiming to mop up $50 million worth of its common stock with a sweet deal that’s sure to grab any investor's attention....